Yamade M - Search Results

1

Expectations for the Dual Therapy with Vonoprazan and Amoxicillin for the Eradication of H. pylori.

Furuta T, Yamade M, Higuchi T, Takahashi S, Ishida N, Tani S, Tamura S, Iwaizumi M, Hamaya Y, Osawa S, Sugimoto K. Furuta T, et al. Among authors: yamade m. J Clin Med. 2023 Apr 25;12(9):3110. doi: 10.3390/jcm12093110. J Clin Med. 2023. PMID: 37176551 Free PMC article. Review.

2

CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell Lines.

Rajapakse VN, Luna A, Yamade M, Loman L, Varma S, Sunshine M, Iorio F, Sousa FG, Elloumi F, Aladjem MI, Thomas A, Sander C, Kohn KW, Benes CH, Garnett M, Reinhold WC, Pommier Y. Rajapakse VN, et al. Among authors: yamade m. iScience. 2018 Dec 21;10:247-264. doi: 10.1016/j.isci.2018.11.029. Epub 2018 Dec 12. iScience. 2018. PMID: 30553813 Free PMC article.

3

Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori.

Furuta T, Shirai N, Kodaira M, Sugimoto M, Nogaki A, Kuriyama S, Iwaizumi M, Yamade M, Terakawa I, Ohashi K, Ishizaki T, Hishida A. Furuta T, et al. Among authors: yamade m. Clin Pharmacol Ther. 2007 Apr;81(4):521-8. doi: 10.1038/sj.clpt.6100043. Epub 2007 Jan 10. Clin Pharmacol Ther. 2007. PMID: 17215846 Clinical Trial.

4

Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori.

Furuta T, Sugimoto M, Shirai N, Matsushita F, Nakajima H, Kumagai J, Senoo K, Kodaira C, Nishino M, Yamade M, Ikuma M, Watanabe H, Umemura K, Ishizaki T, Hishida A. Furuta T, et al. Among authors: yamade m. Aliment Pharmacol Ther. 2007 Sep 1;26(5):693-703. doi: 10.1111/j.1365-2036.2007.03408.x. Aliment Pharmacol Ther. 2007. PMID: 17697203 Free article.

5

Treatment strategy to eradicate Helicobacter pylori infection: impact of pharmacogenomics-based acid inhibition regimen and alternative antibiotics.

Sugimoto M, Furuta T, Shirai N, Kodaira C, Nishino M, Yamade M, Ikuma M, Watanabe H, Ohashi K, Hishida A, Ishizaki T. Sugimoto M, et al. Among authors: yamade m. Expert Opin Pharmacother. 2007 Nov;8(16):2701-17. doi: 10.1517/14656566.8.16.2701. Expert Opin Pharmacother. 2007. PMID: 17956193 Review.

6

MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese.

Sugimoto M, Furuta T, Shirai N, Kodaira C, Nishino M, Yamade M, Ikuma M, Sugimura H, Ishizaki T, Hishida A. Sugimoto M, et al. Among authors: yamade m. Life Sci. 2008 Aug 15;83(7-8):301-4. doi: 10.1016/j.lfs.2008.06.022. Epub 2008 Jul 3. Life Sci. 2008. PMID: 18644389

7

Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan.

Sugimoto M, Furuta T, Kodaira C, Nishino M, Yamade M, Ikuma M, Sugimura H, Hishida A. Sugimoto M, et al. Among authors: yamade m. J Gastroenterol. 2008;43(10):751-61. doi: 10.1007/s00535-008-2221-6. Epub 2008 Oct 29. J Gastroenterol. 2008. PMID: 18958543

8

Effect of MDR1 C3435T polymorphism on lansoprazole in healthy Japanese subjects.

Kodaira C, Sugimoto M, Nishino M, Yamade M, Shirai N, Uchida S, Ikuma M, Yamada S, Watanabe H, Hishida A, Furuta T. Kodaira C, et al. Among authors: yamade m. Eur J Clin Pharmacol. 2009 Jun;65(6):593-600. doi: 10.1007/s00228-009-0625-8. Epub 2009 Feb 24. Eur J Clin Pharmacol. 2009. PMID: 19238367

9

CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole.

Furuta T, Sugimoto M, Kodaira C, Nishino M, Yamade M, Ikuma M, Shirai N, Watanabe H, Umemura K, Kimura M, Hishida A. Furuta T, et al. Among authors: yamade m. Eur J Clin Pharmacol. 2009 Jul;65(7):693-8. doi: 10.1007/s00228-009-0628-5. Epub 2009 Mar 4. Eur J Clin Pharmacol. 2009. PMID: 19259653

10

[13C]-pantoprazole breath test to predict CYP2C19 phenotype and efficacy of a proton pump inhibitor, lansoprazole.

Furuta T, Kodaira C, Nishino M, Yamade M, Sugimoto M, Ikuma M, Hishida A, Watanabe H, Umemura K. Furuta T, et al. Among authors: yamade m. Aliment Pharmacol Ther. 2009 Aug;30(3):294-300. doi: 10.1111/j.1365-2036.2009.04044.x. Epub 2009 May 18. Aliment Pharmacol Ther. 2009. PMID: 19459830 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page